These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

519 related articles for article (PubMed ID: 24846507)

  • 41. Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Cavalcante R; Sotomi Y; Zeng Y; Lee CW; Ahn JM; Collet C; Tenekecioglu E; Suwannasom P; Onuma Y; Park SJ; Serruys PW
    Heart; 2017 Mar; 103(6):428-433. PubMed ID: 27651390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 43. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PCI versus CABG for multivessel coronary disease in diabetics.
    Tarantini G; Ramondo A; Napodano M; Favaretto E; Gardin A; Bilato C; Nesseris G; Tarzia V; Cademartiri F; Gerosa G; Iliceto S
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):50-8. PubMed ID: 19089938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of prior intracoronary stenting on late outcomes of coronary artery bypass surgery in diabetics with triple-vessel disease.
    Nauffal V; Schwann TA; Yammine MB; El-Hage-Sleiman AK; El Zein MH; Kabour A; Engoren MC; Habib RH
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1302-9. PubMed ID: 25772280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age.
    Hannan EL; Zhong Y; Berger PB; Walford G; Curtis JP; Wu C; Venditti FJ; Higgins RS; Smith CR; Lahey SJ; King SB
    Am J Cardiol; 2014 Mar; 113(5):803-8. PubMed ID: 24440331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcomes of percutaneous versus surgical revascularization in patients with diabetes and left main coronary artery disease: A meta-analysis of randomized controlled trials.
    Carvalho PEP; Veiga TMA; Machado FSL; Porto GV; Pirez J; Rivera M; Melo PC; Braghiroli J; Cardoso R
    J Card Surg; 2022 Dec; 37(12):4646-4653. PubMed ID: 36259716
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial.
    Kappetein AP; Head SJ; Morice MC; Banning AP; Serruys PW; Mohr FW; Dawkins KD; Mack MJ;
    Eur J Cardiothorac Surg; 2013 May; 43(5):1006-13. PubMed ID: 23413014
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: can newer generation drug-eluting stents bridge the gap?
    Bangalore S; Toklu B; Feit F
    Circ Cardiovasc Interv; 2014 Aug; 7(4):518-25. PubMed ID: 24939927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meta-analysis of randomized controlled trials on the treatment of unprotected left main coronary artery disease: one-year outcomes with coronary artery bypass grafting versus percutaneous coronary artery intervention with drug-eluting stent.
    Kajimoto K; Miyauchi K; Yamamoto T; Daida H; Amano A
    J Card Surg; 2012 Mar; 27(2):152-7. PubMed ID: 22364383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous coronary intervention versus coronary artery bypass graft for left main coronary artery disease: A meta-analysis.
    Gallo M; Blitzer D; Laforgia PL; Doulamis IP; Perrin N; Bortolussi G; Guariento A; Putzu A
    J Thorac Cardiovasc Surg; 2022 Jan; 163(1):94-105.e15. PubMed ID: 32499076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.
    Zhang J; Jiang T; Hou Y; Chen F; Yang K; Sang W; Wu H; Ma Y; Xu F; Chen Y
    Atherosclerosis; 2020 Sep; 308():50-56. PubMed ID: 32713512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of coronary artery bypass grafting and drug-eluting stents in patients with chronic kidney disease and multivessel disease: A meta-analysis.
    Wang Y; Zhu S; Gao P; Zhang Q
    Eur J Intern Med; 2017 Sep; 43():28-35. PubMed ID: 28400078
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
    Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
    Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents.
    Verdoia M; Barbieri L; Kedhi E; Suryapranata H; De Luca G
    Angiology; 2018 Oct; 69(9):812-824. PubMed ID: 29661004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials.
    Verma S; Farkouh ME; Yanagawa B; Fitchett DH; Ahsan MR; Ruel M; Sud S; Gupta M; Singh S; Gupta N; Cheema AN; Leiter LA; Fedak PW; Teoh H; Latter DA; Fuster V; Friedrich JO
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):317-28. PubMed ID: 24622417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients.
    Panoulas VF; Ilsley CJ; Kalogeras K; Khan H; Monteagudo Vela M; Dalby M; Kabir T; Smith RD; Mason M; Grocott-Mason R; Cummings I; Lüscher TF; Raja SG
    Eur J Cardiothorac Surg; 2019 Nov; 56(5):911-918. PubMed ID: 31079151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.